Fidelity Investments
CMMB

Fidelity Investments’s Chemomab Therapeutics CMMB Stock Holding History

Fidelity Investments’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-339
Closed -$50K – 3827
2019
Q3 		$50K Sell
339
-119
-26% -$23.1K ﹤0.01% 2868
2019
Q2 		$132K Sell
458
-214
-32% -$74.4K ﹤0.01% 2700
2019
Q1 		$288K Buy
+672
New +$340K ﹤0.01% 2551

Other funds holding CMMB

MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Fidelity Investments's CMMB Position: Q4 2019 in Review

Fidelity Investments sold out of Chemomab Therapeutics (CMMB) in Q4 2019, closing a stake of 339 shares — an estimated $50K sold.

Fidelity Investments first reported a position in CMMB in Q1 2019 and held it in 3 quarters. The position peaked at $288K in Q1 2019. 5 funds tracked by Wall St. Rank hold CMMB as of Q4 2019.

  • Fidelity Investments reported no remaining Chemomab Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Fidelity Investments sold 339 Chemomab Therapeutics shares in Q4 2019, an estimated $50K.
  • Fidelity Investments first reported a position in Chemomab Therapeutics in Q1 2019 and held it in 3 quarters.
  • Fidelity Investments's Chemomab Therapeutics position peaked at $288K in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q4 2019.

Based on Fidelity Investments's 13F filing for Q4 2019, filed 7 Feb 2020.